Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

28.60USD
17 Apr 2014
Price Change (% chg)

$0.07 (+0.25%)
Prev Close
$28.53
Open
$28.48
Day's High
$28.70
Day's Low
$28.48
Volume
829,066
Avg. Vol
976,333
52-wk High
$34.72
52-wk Low
$28.14

ZTS.N

Chart for ZTS.N

About

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs,... (more)

Overall

Beta: --
Market Cap (Mil.): $14,320.86
Shares Outstanding (Mil.): 500.73
Dividend: 0.07
Yield (%): 1.01

Financials

  ZTS.N Industry Sector
P/E (TTM): 28.39 33.23 33.33
EPS (TTM): 1.01 -- --
ROI: 9.82 19.68 18.94
ROE: 20.30 20.37 19.69
Search Stocks

New U.S. FDA rules aim to cut antibiotic use in farm animals

- In a bid to stem a surge in human resistance to certain antibiotics, U.S. regulators announced new guidelines to phase out their use as a growth enhancer in livestock.

12 Dec 2013

UPDATE 3-New U.S. FDA rules aim to cut antibiotic use in farm animals

Dec 11 - In a bid to stem a surge in human resistance to certain antibiotics, U.S. regulators announced new guidelines to phase out their use as a growth enhancer in livestock.

12 Dec 2013

FDA official says Zoetis, Eli Lilly support antibiotic strategy

- Animal health companies Zoetis Inc and Eli Lilly & Co support the U.S. Food and Drug Administration's new voluntary phase-out of antibiotic use in animal production, the agency said during a conference call with reporters.

11 Dec 2013

FDA official says Zoetis, Eli Lilly support antibiotic strategy

Dec 11 - Animal health companies Zoetis Inc and Eli Lilly & Co support the U.S. Food and Drug Administration's new voluntary phase-out of antibiotic use in animal production, the agency said during a conference call with reporters.

11 Dec 2013

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF74.70 +0.35
Merck & Co., Inc. (MRK.N) $56.47 +0.21
Bayer AG (BAYGn.DE) €93.59 +0.66
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.48 +0.71
Eli Lilly and Co (LLY.N) $60.43 +0.47

Earnings vs. Estimates

Search Stocks